1.
Kanani PR, Pillai A. A comparative study of effectiveness, safety and cost effectiveness of olanzapine, risperidone and aripiprazole therapy in schizophrenia. Int J Basic Clin Pharmacol [Internet]. 2020 Apr. 23 [cited 2025 Jun. 14];9(5):786-91. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/4047